SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-014983
Filing Date
2020-06-02
Accepted
2020-06-02 21:12:43
Documents
2
Period of Report
2020-06-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6022
2 EX-24 DOCUMENT attachment1.htm EX-24 4760
  Complete submission text file 0000899243-20-014983.txt   12176
Mailing Address C/O AEGLEA BIOTHERAPEUTICS, INC. 901 S. MOPAC EXPRESSWAY, SUITE 250 AUSTIN TX 78746
Business Address
Bruhn Suzanne Louise (Reporting) CIK: 0001517790 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39303 | Film No.: 20938748

Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Issuer) CIK: 0001746473 (see all company filings)

IRS No.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations